Dauntless Pharmaceuticals, Inc. develops specialty pharmaceutical drugs via a one-asset, one-company model that is structured to facilitate operational efficiencies. Dauntless 1, its first asset company, was formed to develop DP1038, a therapeutic agent for the treatment of acromegaly and neuroendocrine tumors. Dauntless Pharmaceuticals, started in 2015, has raised committed capital of $32 million from its founding investor, Sofinnova, along with Canaan Partners who led the most recent financing. The funds are dedicated to the advancement of the first asset, DP1038, and an undisclosed second asset.
| Website | http://www.dauntlessph.com |
| Revenue | $10.4 million |
| Employees | 1 (1 on RocketReach) |
| Address | 9920 Pacific Heights Blvd Ste 150, San Diego, California 92121, US |
| Phone | +1 858-999-3053 |
| Industry | Media & Internet General, Media & Internet |
| Competitors | Red Dot Payment, Smartpay, NetPay Limited, Equifax Commercial, ecoPayz, EZPay Financial Services, Inc., Celestial Payments, Swiftpay, Paylite NG, Snappay +14 more (view full list) |
| SIC | SIC Code 781 Companies, SIC Code 78 Companies |
| NAICS | NAICS Code 512 Companies, NAICS Code 51 Companies, NAICS Code 5121 Companies, NAICS Code 51211 Companies, NAICS Code 512110 Companies |
Looking for a particular Dauntless Studios employee's phone or email?
Dauntless Studios Questions
The Dauntless Studios annual revenue was $10.4 million in 2026.
1 people are employed at Dauntless Studios.
Dauntless Studios is based in San Diego, California.
The NAICS codes for Dauntless Studios are [512, 51, 5121, 51211, 512110].
The SIC codes for Dauntless Studios are [781, 78].
